Literature DB >> 29301093

Biomolecules in the treatment of lichen planus refractory to corticosteroid therapy: Clinical and histopathological assessment.

Laura Piñas1, Mohammad Hamdan Alkhraisat2, Ricardo Suárez-Fernández3, Eduardo Anitua4.   

Abstract

BACKGROUND: Local deficit of several biomolecules have been described in oral lichen planus (OLP). Such a deficit impairs cellular functions and cell-matrix communication.
PURPOSE: Assess the efficacy of the local application of autologous biomolecules in the treatment of erosive OLP.
MATERIALS AND METHODS: In this study, the use of plasma rich in growth factors (PRGF) as a source of blood-derived and autologous growth factors and proteins were tested in erosive oral lichen planus refractory to corticosteroids. Histopathological features of the disease were also analysed at the time of diagnosis. Clinical data were the number of recurrences and achievement of pain reduction and complete healing of the lesions. A total of 10 patients with erosive OLP refractory to treatment by corticosteroids were included in the study. All patients were females with a mean age of 48±12years.
RESULTS: A complete remission of the disease was achieved after one infiltration of PRGF in 8 patients. Only 2 patients required a total of 2 infiltrations to heal. Hydropic degeneration of the epithelium basal layer, band-like subepithelial lymphocytic infiltration and fibrin deposits in the epithelium were observed in all patients. Interestingly plasma cells were present in 2 patients. All patients presenting plasma cells healed after only one PRGF infiltration. However, 2 patients out of 6 (no plasma cells) required 2 infiltrations.
CONCLUSIONS: The local administration of autologous local factors could overcome the deficit of biomolecular clues and thus improve cell functions and restore cell-matrix communication.
Copyright © 2017 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Corticosteroids; Growth factors; Oral lichen planus; PRGF; PRP

Mesh:

Substances:

Year:  2018        PMID: 29301093     DOI: 10.1016/j.aanat.2017.12.006

Source DB:  PubMed          Journal:  Ann Anat        ISSN: 0940-9602            Impact factor:   2.698


  4 in total

Review 1.  Platelet-Rich Plasma as an Alternative to Xenogeneic Sera in Cell-Based Therapies: A Need for Standardization.

Authors:  Eduardo Anitua; Mar Zalduendo; Maria Troya; Mohammad H Alkhraisat; Leticia Alejandra Blanco-Antona
Journal:  Int J Mol Sci       Date:  2022-06-11       Impact factor: 6.208

2.  Efficacy of platelet-rich fibrin compared with triamcinolone acetonide as injective therapy in the treatment of symptomatic oral lichen planus: a pilot study.

Authors:  Francesco Bennardo; Francesco Liborio; Selene Barone; Alessandro Antonelli; Caterina Buffone; Leonzio Fortunato; Amerigo Giudice
Journal:  Clin Oral Investig       Date:  2021-01-07       Impact factor: 3.573

3.  Efficacy of injectable platelet-rich fibrin in the erosive oral lichen planus: a split-mouth, randomized, controlled clinical trial.

Authors:  Ebru Saglam; Zeliha Betul Ozsagir; Tugba Unver; Suzan Bayer Alinca; Ali Toprak; Mustafa Tunali
Journal:  J Appl Oral Sci       Date:  2021-10-04       Impact factor: 2.698

4.  Autologous Platelet Rich Plasma (PRGF) Preserves Genomic Stability of Gingival Fibroblasts and Alveolar Osteoblasts after Long-Term Cell Culture.

Authors:  Eduardo Anitua; María de la Fuente; María Troya; Mar Zalduendo; Mohammad Hamdan Alkhraisat
Journal:  Dent J (Basel)       Date:  2022-09-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.